CClinicalTrials.gg
Sign In
WithdrawnNCT05016921Updated Apr 4, 2024

TcMS to Treat Ventricular Tachycardia

An interventional study of TcMS in Ventricular Tachycardia, sponsored by University of Pennsylvania. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-04.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Alternate study pursued
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Open label study of transcutaneous magnetic stimulation targeting the stellate ganglion in patients with ventricular tachycardia

02

Conditions studied

  • Ventricular Tachycardia
03

In context

Tachycardia

623 studies on the registry are indexed under Tachycardia; 81 are open to participants now.

Browse Tachycardia studies →

Lead sponsor

University of Pennsylvania is the lead sponsor of 1,635 studies on the registry; 239 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 104 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age >18years
  • Documented ventricular tachycardia within the preceding 72 hours

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Implanted ventricular assist device
  • Metal implanted in heard or neck (except the mouth)
  • Implanted medication pumps
  • Cochlear implant
  • Implanted brain stimulator
  • Ocular implant
  • History of malignancy in the region of stimulation (neck)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Transcutaneous magnetic stimulation

    Transcutaneous magnetic stimulation targeting the stellate ganglion

    Device: TcMS

Interventions

  • DeviceTcMS

    Transcutaneous magnetic stimulation targeting the stellate ganglion

06

What researchers measure

Primary outcomes

  1. Ventricular Tachycardia

    Burden (number of episodes) of ventricular tachycardia

    Time frame: 0-72 hours after enrollment

Secondary outcomes

  1. Non sustained ventricular tachycardia

    Burden (number of episodes) of ventricular tachycardia

    Time frame: 0-72 hours after enrollment

  2. Discomfort

    Discomfort experienced during stimulation (on scale of 0-10) reported by patient

    Time frame: Assessed immediately following stimulation

07

Study locations

1 site
  • Hospital of the University of Pennsylvania
    Philadelphia, Pennsylvania 19104, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05016921
Lead sponsor
University of Pennsylvania
Responsible party
Sponsor
First posted
Aug 23, 2021
Start date
Jan 1, 2024
Primary completion
Jan 1, 2024
Completion
Jan 1, 2024 (estimated)
Last update
Apr 4, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Tachycardia→

Other studies from this sponsor

University of Pennsylvania

Start the discussion